Geriatric Psychiatry Review: Differential Diagnosis and Treatment of the 3 D’s - Delirium, Dementia, and Depression
Geriatric Disorders (H Lavretsky, Section Editor)
First Online: 02 May 2013 DOI:
10.1007/s11920-013-0365-4 Cite this article as: Downing, L.J., Caprio, T.V. & Lyness, J.M. Curr Psychiatry Rep (2013) 15: 365. doi:10.1007/s11920-013-0365-4 Part of the following topical collections: Topical Collection on Geriatric Disorders Abstract
The three D’s of Geriatric Psychiatry—delirium, dementia, and depression—represent some of the most common and challenging diagnoses for older adults. Delirium is often difficult to diagnose and treatment is sometimes controversial with the use of antipsychotic medications, but it is common in a variety of patient care settings and remains an independent risk factor for morbidity and mortality in older adults. Dementia may affect a significant number of older adults and is associated with delirium, depression, frailty, and failure to thrive. Treatment of dementia is challenging and while medication interventions are common, environmental and problem solving therapies may have some of the greatest benefits. Finally, depression increases with age and is more likely to present with somatic complaints or insomnia and is more likely to be reported to a primary care physician than any other healthcare provider by older adults. Depression carries an increased risk for suicide in older adults and proven therapies should be initiated immediately. These three syndromes have great overlap, can exist simultaneously in the same patient, and often confer increased risk for each other. The primary care provider will undoubtedly benefit from a solid foundation in the identification, classification, and treatment of these common problems of older adulthood.
Keywords Psychiatry Primary care Delirium Dementia Depression Geriatric Elderly Aging Mental health
This article is part of the Topical Collection on
Geriatric Disorders References Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Cole MG, McCusker J, Voyer P, et al. Subsyndromal delirium in older long-term care residents. Incidence, risk factors, and outcomes. J Am Geriatr Soc. 2011;59:1829–36.
This prospective cohort study of older adults describes risk factors for developing delirium in long-term care residents.
Lyness JM. Delirium: masquerades and misdiagnosis in elderly inpatients. J Am Geriatr Soc. 1990;38(11):1235–8.
Voyer P, McMusker J, Cole MG, et al. Prodrome of delirium among long term care residents: what clinical changes can be observed in the two weeks preceding a full-blown episode of delirium? Int Psychogeriatr. 2012;24(11):1855–64.
• Witlox J, Eurelings LS, de Jonghe JF, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304(4):443–51.
This meta-analysis showed long-term poor outcomes after delirium in older patients.
•• Flaherty JH, Gonzales JP, Dong B. Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc. 2011;59:S269–276.
This systematic literature review did not support the use of antipsychotics in the treatment of delirium in older hospitalized patients.
•• Morandi A, McCurley J, Vasilevskis EE, et al. Tools to detect delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2012;60(11):2005–13.
This systematic literature review validated the CAM as a sensitive and specific tool for detecting delirium in the setting of dementia.
Inouye SK, Van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941–8.
Kopke S, Muhlhauser, Gerlach A, et al. Effect of a guideline-based multicomponent intervention on use of physical restraints in nursing homes. JAMA. 2012;307(20):2177–84.
Morley JE. Behavioral management in the person with dementia. J Nutr Health Aging. 2013;17(1):35–8.
Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012;30(11):1206–14.
National Institute for Health and Clinical Excellence. NICE clinical guideline 103: Delirium: diagnosis, prevention and management. July 2010.
•• Saczynski JS, Marcantonio ER, Quach L, et al. Cognitive trajectories after postoperative delirium. NEJM. 2012;367(1):30–9.
This observational study found significant delirium risk with prolonged impact on cognitive functioning in older post-operative patients who underwent cardiac surgery.
Davis DH, Terrera GM, Keage H, et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135:2809–16.
Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord. 2012;6(1):19–33.
Kalapatapu RK, Neugroschl JA. Update on neuropsychiatric symptoms of dementia: evaluation and management. Geriatrics. 2009;64(4):20–6.
US Preventative Task Force: Screening for Dementia. Release Date: June 2003. Available at:
. Accessed March 2013.
Newman JC, Feldman RF. Perspective-copyright and open access at the bedside. NEJM. 2011;365:2447–9.
Dong Y, Lee WY, Basri NA, et al. The Montreal cognitive assessment is superior to the mini-mental state examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012;24(11):1749–55.
Geda YE, Silber TC, Roberts RO, et al. Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study. Mayo Clin Proc. 2012;87(5):437–42.
Meng X, D’Arcy C. Education and dementia in the contrext of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268.
Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardized Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomized placebo-controlled trial. Lancet Neurol. 2012;11(10):85109.
St DK, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008;300(19):2253–62.
Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008;Oct(4):CD004514.
Syndenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;6, CD005379.
Aisen PS, Schafer KA, Grundman M, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA. 2003;289(21):2819–26.
• Alexopoulos GS, Raue PJ, Kiosses DN, et al. Problem solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68(1):33–41.
This prospective cohort study of older adults describes risk factors for developing delirium in long-term care residents.
Mukamel DB, Caprio TV, Ahn R, et al. End-of-life quality-of-care measures for nursing homes: place of death and hospice. J Palliat Med. 2012;15(4):438–46.
Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415–9.
Kim SY, Caine ED, Currier GW, et al. Assessing the competence of persons with Alzheimer’s disease in providing informed consent for participation in research. Am J Psychiatry. 2001;158(5):712–7.
Carroll DW. Assessment of capacity for medical decision making. J Gerontol Nurs. 2010;36(5):47–52.
Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.
Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58(5):880–8.
Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. JAMA. 2011;306(12):1359–69.
Kalapatapu RK, Schimmin C. Update on neuropsychiatric symptoms of dementia: antipsychotic use. Geriatrics. 2009;64(5):10–8.
Devanand DP, Pelton GH, Cunqueiro K, et al. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer’s disease. Int J Geriatr Psychiatry. 2011;26(9):937–43.
Murse J, Robien K, Harnack LJ, et al. Dietary supplements and mortality rate in older women: the Iowa women’s health study. Arch Intern Med. 2011;171(18):1625–33.
Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.
Andrew MK, Fisk JD, Rockwood K. Psychological well-being in relation to frailty: a frailty identity crisis? Int Psychogeriatr. 2012;24(8):1347–53.
Rodriguez-manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7.
NiMhaolain AM, Fan CW, Romero-Ortuno R, et al. Frailty, depression, and anxiety in later life. Int Psychogeriatr. 2012;24(8):1265–74.
•• Boyle LL, Porteinsson AP, Cui X, et al. Depression predicts cognitive disorders in older primary care patients. J Clin Psychiatry. 2010;71(1):74–9.
This prospective cohort study showed that depression is associated with development of cognitive decline in older patients.
•• Firbank MJ, Teodorczuk A, van der Flier WM, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. BJP. 2012;201:40–5.
This longitudinal study showed that progression of white matter changes was significantly associated with incidence of depression in older patients.
Lyness JM, Yu Q, Tang W, et al. Risks for depression onset in primary care elderly patients: potential targets for preventive interventions. Am J Psychiatry. 2009;166(12):1375–83.
Harmon JS, Veazie PJ, Lyness JM. Primary care physician office visits for depression by older Americans. J Gen Intern Med. 2006;21:926–30.
Bland P. Tackling anxiety and depression in older people in primary care. Practitioner. 2012;256(1747):17–20.
Lyness JM, Chapman BP, McGriff J, et al. One-year outcomes of minor and subsyndromic depression in older primary care patients. Int Psychogeriatr. 2009;21(1):60–8.
• Byers AL, Vittinghoff E, Lui L, et al. Twenty-year depressive trajectories among older women. Arch Gen Psychiatry. 2012;69(10):1073–9.
This prospective cohort study followed women with depression from age 65 years old to 85 years old and found many women with persistent or worsening depression symptoms over time.
Ellison JM, Kyomen HH, Harper DG. Depression in later life: an overview with treatment recommendations. Psychiatr Clin N Am. 2012;35:203–29.
Maurer DM. Screening for depression. Am Fam Physician. 2012;85(2):140–4.
Bloom HG, Ahmed I, Alessi CA, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc. 2009;57(5):761–89.
Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for the onset of depression in the elderly. Behav Sleep Med. 2006;4(2):104–13.
Tang QK, Lu JY, Liang H, et al. Is insomnia associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92(12):2025–7.
•• Martin JL, Fiorentino L, Jouldjian S, et al. Poor self-reported sleep quality predicts mortality within one year of inpatient post-acute rehabilitation among older adults. Sleep. 2011;34(12):1715–21.
This prospective cohort study found increased mortality associated with poor self-reported sleep quality despite objectively measured sleep parameters in the post-acute rehab setting.
Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012;10(4):266–79.
Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010;123:1087–90.
Garzon C, Guerrero JM, Aramburu O, et al. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res. 2009;21(1):38–42.
Heisel MJ, Duberstein PR, Lyness JM, et al. Screening for suicide ideation among older primary care patients. J Am Board Fam Med. 2010;23(2):260–9.
Cohen A, Chapman BP, Gilman SE, et al. Social inequalities in the occurrence of suicidal ideation among older primary care patients. Am J Geriatr Psychiatry. 2010;18(12):1146–54.
• Tang WK, Chen YK, Liang HJ, et al. Cerebral microbleeds and suicidality in stroke. Psychosomatics. 2012;53:439–45.
This prospective cohort study found increased suicidal ideation among older stroke patients, particularly in those with lobar or thalamic hemorrhages.
Taylor MH, Grossbery GT. The growing problem of illicit substance abuse in the elderly: a review. Prim Care Companion CNS Disord. 2012;14(4). doi:
Mottam PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. The Cochrane Library. 2009. p. 1-69.
Pinquart M, Duberstein PR, Lyness JM. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry. 2006;163:1493–501.
Andreeva VA, Galan P, Torres M, et al. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the supplementation with FOLate, vitamins B-6 and B-12 and/or Omega-3 fatty acids (SU.FOL.OM3) randomized trial. Am J Clin Nutr. 2012;96(1):208–14.
Dyck CH, Lyness JM, Rohrbaugh RM, et al. Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study. Int Psychogeriatr. 2009;21(1):138–47.
Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2012;86(4):203–15.
Lavretsky H. Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders. Aging health. 2009;5(1):61–78.
Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357:1939.
George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67:507–16.
Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45:569–76.
Holzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150–8.
Hatfield JP, Hirsch JK, Lyness JM. Functional impairment, illness burden, and depressive symptoms in older adults: does type of social relationship matter? Int J Geriatr Psychiatry. 2013;28:190–8.
Sirey J, Hannon CP, D’Angelo D, et al. A community treatment intervention AdVancing Active Treatment in the Elderly (ACTIVATE): a pilot study. J Gerent Soc Work. 2012;55:382–91.
CrossRef Copyright information
© Springer Science+Business Media New York 2013